Bio-Techne Corp

TECH | $63.48 -0.33% -0.33% 980K

(0.0% 1d) (-7.1% 1m) (-19.0% 1y) (0.0% 2d) (-0.3% 3d) (2.3% 7d) (-19.09% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 9,978,528,164
http://www.bio-techne.com
Sec Filling | Patents | 2300 employees

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Protein Sciences and Diagnostics &Genomics. The Protein Sciences segment develops and manufactures purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. This segment also includes protein analysis solutions that offer researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics &Genomics segment develops and manufactures diagnostic products, including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. This segment also manufactures and sells advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use. The company was founded on 1976 and is headquartered in Minneapolis, MN.

cancer prostate cancer antibody molecular diagnostics multiplexing t-cell diagnostics msa ceiling

add to watch list Paper trade email alert is off

Press-releases

Biochar Market size is set to grow by USD 1.72 billion from 2023-2027, helps in reducing emission boost the market, Technavio
Published: 2024-04-23 (Crawled : 22:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -0.27% | O: -0.74% H: 1.15% C: 0.47%
set market

BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
Published: 2024-04-23 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| 0.91% | O: 1.67% H: 0.91% C: -0.48%
patent molecular

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
Published: 2024-04-10 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -7.58% | O: 1.24% H: 0.85% C: -0.1%
conference financial results

BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Published: 2024-04-08 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -5.55% | O: 0.01% H: 2.32% C: 1.43%
technology

BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
Published: 2024-04-03 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -7.62% | O: -0.68% H: 0.7% C: -0.62%
conference association cancer research

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -8.54% | O: 1.87% H: 0.0% C: -1.89%
year innovation awards

BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Published: 2024-03-22 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -12.18% | O: 0.07% H: 0.1% C: -1.22%
certification test diagnostic leukemia

BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
Published: 2024-03-12 (Crawled : 11:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -15.45% | O: -0.08% H: 0.8% C: -1.27%
life sciences

BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -13.46% | O: 0.04% H: 3.57% C: 1.7%
conference global

IVD Contract Manufacturing Market size to grow by USD 9.37 billion from 2022 to 2027, Asia to account for 37% of market growth, Technavio
Published: 2024-03-01 (Crawled : 02:00) - prnewswire.com
TEL | News | $140.0 -2.26% 0.0% 5.8M

Electronic Technology

| -2.48% | O: -0.19% H: 0.61% C: 0.31%
TECH | $63.48 -0.33% -0.33% 980K

Health Technology

| -13.66% | O: -0.12% H: 1.49% C: 1.22%
contract asia market

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001062993-24-008111	4	2024-04-05	2024-04-03	Sell	M	2259	4519
0001062993-24-008111	4	2024-04-05	2024-04-03	Sell	F	747	1647
0001062993-24-008111	4	2024-04-05	2024-04-03	Buy	M	2259	2394